Inhibiting Glycine Decarboxylase Suppresses Pyruvate-to-Lactate Metabolism in Lung Cancer Cells
Glycine decarboxylase (GLDC) gene is frequently upregulated in various types of cancer including lung, prostate and brain. It catabolizes glycine to yield 5,10-methylenetetrahydrofolate, an important substrate in one-carbon metabolism for nucleotide synthesis. In this study, we used exon splicing mo...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2018.00196/full |
_version_ | 1811253322009542656 |
---|---|
author | Chern Chiuh Woo Kavita Kaur Wei Xin Chan Xing Qi Teo Teck Hock Philip Lee |
author_facet | Chern Chiuh Woo Kavita Kaur Wei Xin Chan Xing Qi Teo Teck Hock Philip Lee |
author_sort | Chern Chiuh Woo |
collection | DOAJ |
description | Glycine decarboxylase (GLDC) gene is frequently upregulated in various types of cancer including lung, prostate and brain. It catabolizes glycine to yield 5,10-methylenetetrahydrofolate, an important substrate in one-carbon metabolism for nucleotide synthesis. In this study, we used exon splicing modulating steric hindrance antisense oligonucleotide (shAON) to suppress GLDC expression and investigated its effect on pyruvate metabolism via hyperpolarized carbon-13 magnetic resonance spectroscopy (MRS). The MRS technique allows us to study in vivo metabolic flux in tumor tissues with/without GLDC-shAON intervention. Here, we show that GLDC-shAON treatment is able to suppress lung cancer cell growth and tumorigenesis, both in vitro and in vivo. The carbon-13 MRS results indicated that the conversion of pyruvate into lactate in GLDC-shAON-treated tumor tissues was significantly reduced, when compared with the control groups. This observation corroborated with the reduced activity of lactate dehydrogenase and pyruvate dehydrogenase in GLDC-shAON-treated lung cancer cells and tumor tissues. Glycolysis stress test showed that extracellular acidification rate was significantly suppressed after GLDC-shAON treatment. Besides lung cancer, the antitumor effect of GLDC-shAON was also observed in brain, liver, cervical, and prostate cancer cell lines. Furthermore, it enhanced the treatment efficacy of cisplatin in lung cancer cells. Taken together, our findings illustrate that pyruvate metabolism decreases upon GLDC inhibition, thereby starving cancer cells from critical metabolic fuels. |
first_indexed | 2024-04-12T16:49:06Z |
format | Article |
id | doaj.art-a9f8230506884bbeac9e98de3b6e1b8a |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-04-12T16:49:06Z |
publishDate | 2018-06-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-a9f8230506884bbeac9e98de3b6e1b8a2022-12-22T03:24:28ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2018-06-01810.3389/fonc.2018.00196377599Inhibiting Glycine Decarboxylase Suppresses Pyruvate-to-Lactate Metabolism in Lung Cancer CellsChern Chiuh WooKavita KaurWei Xin ChanXing Qi TeoTeck Hock Philip LeeGlycine decarboxylase (GLDC) gene is frequently upregulated in various types of cancer including lung, prostate and brain. It catabolizes glycine to yield 5,10-methylenetetrahydrofolate, an important substrate in one-carbon metabolism for nucleotide synthesis. In this study, we used exon splicing modulating steric hindrance antisense oligonucleotide (shAON) to suppress GLDC expression and investigated its effect on pyruvate metabolism via hyperpolarized carbon-13 magnetic resonance spectroscopy (MRS). The MRS technique allows us to study in vivo metabolic flux in tumor tissues with/without GLDC-shAON intervention. Here, we show that GLDC-shAON treatment is able to suppress lung cancer cell growth and tumorigenesis, both in vitro and in vivo. The carbon-13 MRS results indicated that the conversion of pyruvate into lactate in GLDC-shAON-treated tumor tissues was significantly reduced, when compared with the control groups. This observation corroborated with the reduced activity of lactate dehydrogenase and pyruvate dehydrogenase in GLDC-shAON-treated lung cancer cells and tumor tissues. Glycolysis stress test showed that extracellular acidification rate was significantly suppressed after GLDC-shAON treatment. Besides lung cancer, the antitumor effect of GLDC-shAON was also observed in brain, liver, cervical, and prostate cancer cell lines. Furthermore, it enhanced the treatment efficacy of cisplatin in lung cancer cells. Taken together, our findings illustrate that pyruvate metabolism decreases upon GLDC inhibition, thereby starving cancer cells from critical metabolic fuels.https://www.frontiersin.org/article/10.3389/fonc.2018.00196/fullglycine decarboxylaselung cancerantisense oligonucleotidecarbon-13magnetic resonance spectroscopy |
spellingShingle | Chern Chiuh Woo Kavita Kaur Wei Xin Chan Xing Qi Teo Teck Hock Philip Lee Inhibiting Glycine Decarboxylase Suppresses Pyruvate-to-Lactate Metabolism in Lung Cancer Cells Frontiers in Oncology glycine decarboxylase lung cancer antisense oligonucleotide carbon-13 magnetic resonance spectroscopy |
title | Inhibiting Glycine Decarboxylase Suppresses Pyruvate-to-Lactate Metabolism in Lung Cancer Cells |
title_full | Inhibiting Glycine Decarboxylase Suppresses Pyruvate-to-Lactate Metabolism in Lung Cancer Cells |
title_fullStr | Inhibiting Glycine Decarboxylase Suppresses Pyruvate-to-Lactate Metabolism in Lung Cancer Cells |
title_full_unstemmed | Inhibiting Glycine Decarboxylase Suppresses Pyruvate-to-Lactate Metabolism in Lung Cancer Cells |
title_short | Inhibiting Glycine Decarboxylase Suppresses Pyruvate-to-Lactate Metabolism in Lung Cancer Cells |
title_sort | inhibiting glycine decarboxylase suppresses pyruvate to lactate metabolism in lung cancer cells |
topic | glycine decarboxylase lung cancer antisense oligonucleotide carbon-13 magnetic resonance spectroscopy |
url | https://www.frontiersin.org/article/10.3389/fonc.2018.00196/full |
work_keys_str_mv | AT chernchiuhwoo inhibitingglycinedecarboxylasesuppressespyruvatetolactatemetabolisminlungcancercells AT kavitakaur inhibitingglycinedecarboxylasesuppressespyruvatetolactatemetabolisminlungcancercells AT weixinchan inhibitingglycinedecarboxylasesuppressespyruvatetolactatemetabolisminlungcancercells AT xingqiteo inhibitingglycinedecarboxylasesuppressespyruvatetolactatemetabolisminlungcancercells AT teckhockphiliplee inhibitingglycinedecarboxylasesuppressespyruvatetolactatemetabolisminlungcancercells |